We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

126 hedge funds and large institutions have $451M invested in Emergent Biosolutions in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 62 increasing their positions, 29 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

280% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 5

114% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 29

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

40% more capital invested

Capital invested by funds: $323M → $451M (+$128M)

12% more funds holding

Funds holding: 113 → 126 (+13)

1.92% more ownership

Funds ownership: 64.42% → 66.34% (+1.9%)

Holders
126
Holders Change
+13
Holders Change %
+11.5%
% of All Funds
4.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
19
Increased
62
Reduced
29
Closed
5
Calls
$36K
Puts
–
Net Calls
+$36K
Net Calls Change
+$35K

Top Buyers

Rank Fund Capital Flow
1
SCA
SAC Capital Advisors
Connecticut
+$5.77M
2
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$3.68M
3
BFA
BlackRock Fund Advisors
California
+$3.43M
4
Goldman Sachs
Goldman Sachs
New York
+$2.13M
5
NI
Numeric Investors
Massachusetts
+$1.72M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.13M
2
BNP Paribas Asset Management
BNP Paribas Asset Management
France
-$2.36M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.25M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.79M
5
State Street
State Street
Massachusetts
-$1.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$3.2M +$369K +20,654 +14%
RFC
27
Russell Frank Company
Washington
$3.15M -$453K -25,394 -13%
Wellington Management Group
28
Wellington Management Group
Massachusetts
$3.01M +$891K +49,927 +46%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$2.78M +$105K +5,864 +4%
Millennium Management
30
Millennium Management
New York
$2.62M -$4.13M -231,533 -63%
NI
31
Numeric Investors
Massachusetts
$2.62M +$1.72M +96,508 +236%
GC
32
Guggenheim Capital
Illinois
$2.47M +$69.5K +3,892 +3%
Charles Schwab
33
Charles Schwab
California
$2.47M -$355K -19,906 -14%
Deutsche Bank
34
Deutsche Bank
Germany
$2.35M +$961K +53,811 +77%
Acadian Asset Management
35
Acadian Asset Management
Massachusetts
$2.27M +$106K +5,959 +5%
TC
36
TFS Capital
Pennsylvania
$2.16M +$149K +8,348 +8%
Ameriprise
37
Ameriprise
Minnesota
$2.09M +$253K +14,170 +15%
BIM
38
BlackRock Investment Management
Delaware
$2.04M +$76.9K +4,308 +4%
ERSOT
39
Employees Retirement System of Texas
Texas
$2M – – –
CRC
40
Curi RMB Capital
Illinois
$1.77M +$1.66M +92,963 New
MOACM
41
Mutual of America Capital Management
New York
$1.7M +$40.1K +2,248 +3%
BA
42
BlackRock Advisors
Delaware
$1.69M +$1.27M +71,124 +411%
IG
43
ING Group
Netherlands
$1.61M – – –
SCP
44
Seizert Capital Partners
Michigan
$1.5M +$110K +6,170 +9%
DCM
45
Dupont Capital Management
Delaware
$1.39M +$307K +17,213 +31%
GC
46
Globeflex Capital
California
$1.37M – – –
Public Sector Pension Investment Board (PSP Investments)
47
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.31M +$361K +20,200 +41%
GCP
48
GSA Capital Partners
United Kingdom
$1.27M +$312K +17,493 +36%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$1.26M +$718K +40,200 +154%
PPA
50
Parametric Portfolio Associates
Washington
$1.25M +$101K +5,636 +9%
1
2
3 4 5

EBS Hedge Fund Activity: Q3 2013 in Review

126 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2013, worth a combined $451M — up 40% from $323M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new EBS positions and 5 closed out — a net gain of 14 holders — while 62 added to existing stakes and 29 trimmed.

The largest buyer was SAC Capital Advisors, adding an estimated $5.77M. The largest seller was Millennium Management, cutting an estimated $4.13M.

  • 126 institutional investors held Emergent Biosolutions (EBS) as of Q3 2013, up from 113 in Q2 2013.
  • Funds reported $451M of Emergent Biosolutions stock for Q3 2013, up 40% quarter-over-quarter.
  • 19 funds opened new Emergent Biosolutions positions in Q3 2013 and 5 closed out, a net change of +14 holders.
  • The largest Emergent Biosolutions buyer in Q3 2013 was SAC Capital Advisors, an estimated $5.77M added.
  • The largest Emergent Biosolutions seller in Q3 2013 was Millennium Management, an estimated $4.13M sold.

Based on aggregated 13F filings for Q3 2013.